Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-05 @ 3:12 PM
Study NCT ID:
NCT00094367
Status:
COMPLETED
Last Update Posted:
2010-09-30
First Post:
2004-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-10-16
First Submit QC Date:
None
Study First Post Date:
2004-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-09-29
Last Update Post Date:
2010-09-30
Last Update Post Date Type:
ESTIMATED